Skip to main content

Antipsychotic Pulled

October 12, 2018

Teva Pharmaceuticals USA has issued a voluntary recall for 313 bottles of clozapine orally disintegrating tablets, 12.5 mg, 100-count (NDC 0093-5416-01). According to the October 10, 2018, US Food and Drug Administration (FDA) Enforcement Report, samples tested out-of-specification for disintegration.

The recall affects 313 bottles from lot 34034024B (Exp. 2/20). The tablets were distributed throughout the United States.

Teva Pharmaceuticals voluntarily initiated the recall September 21, 2018. The FDA issued a Class II designation October 1, 2018. The classification communicates that use of the product could cause temporary or medically reversible harm, or a remote possibility of serious harm.

Clozapine is a prescription antipsychotic medication used to treat patients with schizophrenia.

Jolynn Tumolo

For more Pharmacy Learning Network articles, visit the homepage

To learn about Pharmacy Learning Network Live meetings, click here

Back to Top